Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Market Cap	432.71M -46.0%
Revenue (ttm)	1.81B -10.7%
Net Income	4.12M -89.6%
EPS	0.01 -89.5%
Shares Out	510.87M
PE Ratio	105.15
Forward PE	n/a
Dividend	0.04 (4.66%)
Ex-Dividend Date	Dec 1, 2025

Volume	171,652
Average Volume	381,178
Open	82.70
Previous Close	85.20
Day's Range	82.70 - 85.20
52-Week Range	82.70 - 157.00
Beta	0.17
RSI	22.06
Earnings Date	May 26, 2026

About Novolog (Pharm-Up 1966)

Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. It offers medical devices to healthcare institutions and patients in their homes; and medical logistics services to pharmaceutical and medical device companies. The company also produces and disseminates medical content and tools to the general public and medical community; and develops personalized treatment programs and initiates home visits by nurses. In addition, it provides health and medical process management services for corporations; and supplies sterilization services...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1966
• Employees: 916
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: NVLG

Financial Performance

In 2025, Novolog (Pharm-Up 1966)'s revenue was 1.81 billion, a decrease of -10.70% compared to the previous year's 2.02 billion. Earnings were 4.12 million, a decrease of -89.59%.